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Abbreviations (used in manuscript, tables and/or figures) 
 
AdenoCa: Adenocarcinoma 
CI: Confidence interval 
HRs: Hazard ratios 
MeSH: Medical subject headings 
N: Number of studies 
n: Number of patients 
NCI: National Cancer institute (United States) 
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
SCC: Squamous cell carcinoma 
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ABSTRACT (word count: 250)  
Objective: Centralization of health care has been a matter of debate, especially for 
advanced cancer surgery. Clear short-term mortality benefits were described for 
oesophageal cancer surgery conducted at high-volume hospitals and by high-volume 
surgeons. However, the impact of volume on long-term survival after 
oesophagectomy remains unclear.  
Design: The systematic literature search included PubMed, Web of Science, 
Cochrane library, EMBASE, and Science Citation Index, and considered the period 
1990-2013. Eligible articles were those which reported survival (time to death) as 
hazard ratios (HRs) after oesophagectomy for cancer by hospital volume, surgeon 
volume, or hospital type. The fully adjusted HRs for the longest follow-up were the 
main outcomes. Results were pooled by means of meta-analysis, and reported as 
HRs and 95% confidence intervals (CIs). 
Results: Sixteen studies from seven countries met the inclusion criteria. These 
studies reported hospital volume (N=13), surgeon volume (N=4) or hospital type 
(N=4). A survival benefit was found for high-volume hospitals (HR 0.82, CI 0.75-
0.90), and possibly also for high-volume surgeons (HR 0.87, CI 0.74-1.02) compared 
to their low-volume counterparts. No association with survival remained for hospital 
volume after adjustment for surgeon volume (HR 1.01, CI 0.97-1.06; N=2), while a 
survival benefit was found in favour of high-volume surgeons after adjustment for 
hospital volume (HR was 0.91, CI 0.85-0.98; N=2).  
Conclusion: This meta-analysis demonstrated better long-term survival (even after 
excluding early deaths) after oesophagectomy with high-volume surgery, and 
surgeon volume might be more important than hospital volume. These findings 
support centralization to fewer surgeons working at large centres.  
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SUMMARY BOX 
 
What is already known about this subject? 
• Oesophageal cancer has a very poor prognosis, with a 5-years survival of 
only 30% after complete oesophageal cancer resection (oesophagectomy). 
• Oesophagectomy is one of the most complex surgical procedures, entailing a 
substantial risk of severe postoperative complications.  
• Short-term mortality (in-hospital and 30-day postoperative) has shown to be 
lower if operated in high volume hospitals and/or by high volume surgeons. 
Yet, 95% of all patients survive the first 30 days after surgery. 
• Based on these differences in short-term mortality, centralisation of 
oesophagectomy within centres of excellence has been recommended and 
adopted in many countries.  
 
What are the new findings? 
• This meta-analysis demonstrated a better long-term survival after 
oesophagectomy with high-volume surgery. 
• Surgeon volume seems to be more important than hospital volume. 
 
How might it impact on clinical practice in the foreseeable future? 
• Differences in long-term survival imply an ever greater benefit of centralisation 
in number of patient years than already presumed based on short-term 
mortality, since the mortality followed by such surgery is strongly dominated by 
deaths from tumour recurrence rather than procedure-related complications. 
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INTRODUCTION 
Centralization of complex cancer surgery is a topic of debate in several countries. 
Such centralization can improve care by collating multidisciplinary expertise and 
experience, as well as specialized equipment within centres of excellence, and will 
impact the health care budget. Treating more patients should improve the skills of the 
medical team, and adapting specific treatment procedures should facilitate and 
improve patient-tailored care. However, the benefit of such centralization should  be 
weighed up against the potential disadvantages for patients, e.g. long travel times 
and social isolation.[1]  Oesophageal cancer surgery is one of the most complex 
surgical procedures, entailing a substantial risk of severe postoperative 
complications, and a convincing benefit of centralization of has been shown for short-
term mortality (in-hospital and 30-day post-operatively) for this surgery.[2-7] 
However, the existing data addressing oesophageal cancer surgery volume in 
relation to long-term survival is limited, and the results from individual studies are 
contradictory.[7] Moreover, the influence of tumour stage has not always been taken 
into account in previous research, which is of major concern whenever long-term 
mortality is the outcome. Thus, the impact of surgery volume on long-term survival 
after oesophageal cancer remains to be established. Such knowledge would be of 
clinical importance since tumour recurrence in oesophageal cancer is common, 
resulting in an approximately 60-70% risk of death within 5 years of surgery.[8, 9] The 
objective of this study was to clarify the association between hospital volume, 
surgeon volume and hospital type in relation to long-term survival after 
oesophagectomy for cancer, by means of a meta-analysis. 
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METHODS 
This was a systematic review and meta-analysis analysing differences in long-term 
survival between high-volume and low-volume hospitals and surgeons after 
oesophagectomy for cancer. The available literature was identified and examined by 
means of a systematic review and survival meta-analysis. The results are reported in 
accordance with the PRISMA guidelines (‘Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses’).[10] The study followed an a priori established study 
protocol.  
 
Exposure and outcome 
The main exposure was surgery performed in either low- or high-volume hospitals, as 
defined by the authors of the included studies. Other examined exposures were 
surgeon volume (low or high) and type of hospital (e.g. university or non-university). 
Both surgeon and hospital volume were measured as the average annual number of 
oesophagectomies per year (e.g. more or less than 10 procedures/per year). The 
group with the lowest volume or non-university was used as reference category. If an 
included study reported hazard ratios (HRs) for different surgical volume groups, only 
the lowest and highest volume group were compared and reported in the forest plots.    
The study outcome was the time to death after the oesophagectomy, defined by a 
minimal period of follow-up of the study cohort of three months.  
 
Data sources and searches 
The primary data sources screened were PubMed and the Web of Science. The 
search string in these databases consisted of four parts: (1) the anatomical location 
of interest (i.e. oesophagus, oesophagectomy, and oesophageal), (2) surgery, 
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surgical or cancer, (3) outcome, mortality, survival or prognosis, and (4) volume, 
determinants or predictors. Different spelling was accounted for, and medical 
subheadings (MeSH) were incorporated in the PubMed search. Complementary 
searches were performed through analyses of reference lists, the Science Citation 
index, Cochrane library, EMBASE, and searching for relevant publications of ‘expert’ 
authors (known or identified to have published in the field of surgery volume).  
 
Study selection 
The time period for publications was limited to January 1990 to September 2013, a 
period which we considered to represent modern oesophageal cancer management. 
The search method to identify all relevant articles was discussed and developed by 2 
authors (NB and JL) and the final search string was approved by all authors. The 
initial search was performed by one reviewer (N.B.) who eliminated clearly irrelevant 
articles based on the title and abstract as defined by the pre-set selection criteria. 
The final selection of the articles was made by mutual consideration of all authors, 
based on the reporting of all necessary data and in accordance with the pre-defined 
inclusion and exclusion criteria.  
 
Inclusion and exclusion criteria 
Studies that provided original data on survival of patients who underwent 
oesophagectomy for malignancy were included. Abstracts or other conference 
proceedings, case reports, case series, intervention studies and review articles were 
excluded. Both prospective and retrospective studies were eligible. Articles 
describing oesophagectomy for non-malignant reasons were excluded, as well as 
studies only reporting a subgroup of oesophagectomy patients. If studies also 
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reported survival after gastric cancer surgery, survival for oesophageal cancer 
needed to be reported separately, otherwise the study was excluded. A language 
restriction was only applied in the end-stage of the search, to enable assessment of 
language selection bias. The languages selected a priori as eligible were English, 
French, Dutch, German, Spanish, Swedish and Chinese. Studies were eligible only if 
HRs comparing survival after oesophagectomy by hospital or surgeon volume 
groups, or by hospital type were reported. The minimum reported follow-up time was 
three months. 
 
Data extraction and quality assessment 
The following data were collected (if available): study and population characteristics, 
type of surgery and hospital characteristics. Assessment of quality and 
generalizability was based on the key domains considered fundamental for 
observational studies.[11] From each article, the crude HRs were extracted (if 
reported), as well as the HRs based on the most fully-adjusted regression models for 
the longest duration of follow-up. If several volume groups were reported, the most 
extreme comparison, i.e. highest versus lowest reported volume, was considered the 
primary result. If possible, the HR for hospital volume adjusted for surgeon volume 
was extracted as well as the most fully-adjusted model without adjustment for 
surgeon volume. The same approach was taken for surgeon volume and adjustment 
for hospital volume. If HRs were reported including and excluding “early” mortality, 
defined as within three months of surgery, both HRs were extracted, but the HR 
including the full follow-up period was considered the main result.  
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Data synthesis and analysis 
This survival meta-analysis pooled the HRs based on hospital volume, surgeon 
volume and hospital type. Sub-analysis was based on duration of follow-up, inclusion 
or exclusion of early mortality, and reported regression models. Random-effect meta-
analyses were performed with STATA (StataCorp, version 12·1/MP4), and were 
based on the HRs and standard errors. The values were reported by means of forest 
plot, and uncertainty of the pooled estimates was quantified by 95% confidence 
intervals (95% CI). If no standard error was reported, it was calculated based on the 
95% CI, number of patients or reported p-values.[12, 13] The presence of small study 
effects and publication bias was evaluated by funnel plots and Egger´s regression 
asymmetry analysis.[14] Statistical heterogeneity was assessed by means of 
Cochran’s Q test and I-squared test. The I-squared represents the percentage of 
variation attributable to heterogeneity, which is usually categorized as low (25-50%), 
moderate (51-75%), or high (>75%).[15]   
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RESULTS 
Description of the included studies 
The search was finalized on September 10th 2013, and included a total of 2392 
publications as shown in the Appendix. The search resulted in 16 eligible studies. 
Only 1 potentially eligible Japanese study was excluded because of the language 
restriction.[16] These were from the United States (N=4),[1, 17-19] Sweden 
(N=4),[20-23] the Netherlands (N=3),[24-26] the United Kingdom (N=2),[27, 28] 
Australia (N=1),[29] Canada (N=1)[30] and Japan (N=1).[31] The longest reported 
follow-up was 23 years.[20] Thirteen studies reported HRs for survival by hospital 
volume groups (n= 39,761),[1, 17, 20-24, 26-31] four by surgeon volume (n= 
2,874),[20, 22, 26, 27] and four by hospital type (n= 13,433).[18, 19, 25, 26] Two of 
the three Dutch studies described the same nationwide cohort, once for hospital 
volume and once for hospital type,[24, 25] and there was some overlap with the third 
(regional) study.[26] The studies from the United Kingdom did not overlap.[27, 28] 
Some overlap was possible in the four American studies.[1, 17-19] The study periods 
of the three oldest (nationwide) Swedish studies partly overlapped.[21-23] An 
overview of the main study characteristics is presented in Table 1, and a quality 
assessment is shown in Figure 1. All but three studies [17, 18, 27] were population-
based, and 10 studies were nationwide. Eight studies also described other cancer 
types. Mean or median age of operated patients ranged from 63 to 66 years, as 
reported in four studies.[1, 20, 21, 30] The proportion of male patients, as reported in 
nine studies, ranged from 71 to 83%. Four studies reported the proportion of the 
main histological types: adenocarcinoma (26-75%) and squamous cell carcinoma 
(22-66%).[20, 21, 24, 25] 
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Hospital volume and long-term survival 
All 13 studies addressing hospital volume reported adjusted HRs. One study 
considered hospital volume as a continuous variable (HR for an increase of 10 
oesophagectomies per year) and reported only HRs adjusted for surgeon 
volume.[27] Another study reported HRs both including and excluding adjustment for 
surgeon volume.[20] Ten studies reported HRs for the complete survival period, two 
of which also reported HRs excluding mortality within the first two months of 
surgery,[1] or as “survived surgery” (not specified).[17] Three studies reported only 
HRs excluding early mortality, i.e. the first two,[23] three,[20] or six[24] postoperative 
months.[20] Six studies adjusted for tumour stage.[1, 17, 20, 22, 24, 31]  
 
The pooled adjusted HRs of mortality in 12 studies (excluding the study adjusting for 
surgeon volume)[27] was 0.82 (95% CI 0.75-0.90) in favour of high-volume hospitals 
(Figure 2). The statistical heterogeneity was moderate (I2= 68.0%). Sub-analyses are 
presented in Table 2, showing a pooled HR of 0.76 (95% CI 0.68-0.84) in studies 
adjusting for tumour stage. The seven studies with the longest complete follow-up 
(over 3 years) showed an HR of 0.77 (95% CI 0.69-0.87), and a survival benefit 
remained after exclusion of early mortality (HR 0.85, 95% CI 0.75-0.95) (Table 2). In 
the two studies reporting complete follow up, and follow-up without early mortality,[1, 
17] the HRs were 0.75 (95% CI 0.69-0.81) and 0.78 (95% CI 0.71-0.85), respectively, 
and I2=0%. In the two studies that adjusted for surgeon volume, the HR was 1.01 
(95% CI 0.97-1.06, I2=0%) (Figure 2).  
There was no evidence of publication bias or small-study effects bias (p=0.313) 
(funnel plot not shown). 
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Surgeon-volume and long-term survival 
The four studies that reported HRs for surgeon volume also reported hospital 
volume.[20, 22, 26, 27] In one study, surgeon and hospital volume were equivalent 
since all oesophagectomies were performed by one surgical team led by one 
surgeon per specialized regional centre.[26] One study reported the HR for surgeon 
volume adjusted for hospital volume as a continuous variable.[27] Another study 
reported HRs with and without adjustment for hospital volume.[20] One study 
reported both hospital and surgeon volume, but did not conduct any mutual 
adjustment for these variables.[22] Only one study excluded early mortality (within 
three months of surgery).[20] The follow-up time ranged from 2 to 23 years.[20, 22, 
26, 27] Only two studies adjusted for tumour stage.[20, 22] 
As presented in Figure 3, the pooled adjusted HR for surgeon volume was 0.87 (95% 
CI 0.74-1.02) in favour of high surgeon volumes. After further adjustment for hospital 
volume, the pooled HR was 0.91 (95% CI 0.85-0.98). Statistical heterogeneity in both 
analyses was low (I2=0%). 
There was no evidence for publication bias or small-study effects bias (p=0.150) 
(funnel plot not shown). 
 
Hospital type and long-term survival 
Four studies analysed hospital type in relation to survival after oesophagectomy.[18, 
19, 25, 26] It was not possible to calculate a pooled HR because of clinical 
heterogeneity between these studies (Figure 4).  
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DISCUSSION 
This meta-analysis indicates a survival benefit in favour of high-volume hospitals and 
high-volume surgeons compared to the low-volume equivalents. No independent risk 
reduction remained for high hospital volume after adjustment for surgeon volume, 
while high surgeon volume remained beneficial after adjustment for hospital volume.   
Strengths of meta-analyses include the fact that they facilitate objective evaluation 
and pooling of different study populations, enable analyses of large and diverse 
cohorts of patients, and summarize the available evidence up to a certain time point. 
Inherent limitations of meta-analyses are that results depend on the availability, 
quality and methods of the published studies, and they might be hampered by 
publication bias as well as clinical and statistical heterogeneity. However, there was 
no evidence of publication bias in this study, and the statistical heterogeneity was low 
to moderate. Language bias cannot be ruled out completely since we based our 
search on English-language dominated sources. Only one potentially eligible study 
was excluded because of the language, [16] but this Japanese study was conducted 
by the same group of an included study.[31] Moreover, even after implementing strict 
inclusion criteria, a considerable clinical heterogeneity remained between study 
populations. Moreover, meta-analyses assessing long-term survival are more 
complex than those evaluating short-term mortality, because of the need to take 
duration of survival and variation in follow-up time into account.  
Despite the heterogeneity between studies, this study provides evidence of improved 
long-term survival when the oesophagectomy is conducted at high-volume hospitals 
and by high-volume surgeons. This distinction of early mortality from long-term 
mortality enables comparison of the underlying mechanisms; when patients die early 
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after surgery it is usually due to complications, while later deaths are typically related 
to cancer recurrence. This study showed that even after excluding the first months 
after surgery, a 15% benefit in favour of high-volume hospitals remained, indicating 
that surgery volume influences the risk of tumour recurrence. These findings support 
centralization of oesophageal cancer surgery to fewer surgeons working at centres of 
excellence in this field.[32-34] The discussion on which hospital and surgeon volume 
should be recommended cannot be answered by this study. As in other meta-
analyses [2, 6] we compared the largest volume group with the lowest volume group 
when different thresholds were used, so based on this study design we cannot define 
a recommended quantity of annual oesophagectomies by hospital or surgeon. The 
findings of the present study complement previous meta-analyses evaluating short-
term mortality after oesophagectomy, with pooled odds ratios of 0.20-0.40 for high-
volume hospitals compared to low-volume hospitals.[2, 4, 6, 35] However, deaths 
from tumour recurrence after oesophageal cancer surgery are far more common (60-
70%) than deaths occurring during the initial postoperative period (<5%), stressing 
the relevance of evaluating surgery volume in relation to longer-term survival. Yet, 
this issue has been addressed only in a few systematic reviews,[4, 6, 36-38] and one 
meta-analysis based on four studies.[6] The previous meta-analysis showed an odds 
ratio of survival of 1.17 (95% CI 1.05-1.31) in favour of high-volume hospitals, but it 
did not take time to death into account.[6] Nevertheless, the finding of that meta-
analysis is in line with the results of the present study. 
An important, yet complex, question is the underlying mechanism of the findings of 
this study, and if hospital and surgeon volumes should be considered separate 
entities or merely proxies of each other. The surgery volume effect might be due to 
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the total package of multidisciplinary teams, advanced diagnostics, treatment and 
care, or alternatively, it might mainly be due to the experience and expertise of the 
surgeon and the surgical team. This study found no association between hospital 
volume and survival when considering only the two studies adjusting for surgeon 
volume, but interestingly, the influence of surgeon volume remained after adjusting 
for hospital volume. Although based on a small number of studies, this might suggest 
a more important role of surgeon volume than hospital volume. 
It is important to point out that survival not only depends on surgery volume.[39] 
Substantial logistical and case-mix differences exist between countries, especially 
considering geographical distances and tumour incidence. A related question is if the 
patient population and case-mix, particularly regarding tumour stage and socio-
economic status, are similar between volume groups.[40, 41]  In an attempt to adjust 
for such confounding, we only included the most adjusted regression models. The six 
studies including adjustment for tumour stage, the strongest prognostic factor, 
showed a larger effect than those which did not adjust (24% versus 9%), which 
indicates robustness of the findings of the present study.  
The size of the effect of high surgery volume in relation to long-term survival after 
oesophageal cancer surgery is not negligible. The effect size is similar to the effect of 
pre-operative oncological therapy that has been demonstrated in recent large meta-
analyses,[42] and neoadjuvant therapy has therefore become routine clinical practice 
in the treatment of these patients in most countries. It therefore seems logical that 
centralization of this surgery should be a prioritized measure to improve the 
prognosis in oesophageal cancer.   
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To conclude, this meta-analysis of long-term survival after oesophageal cancer 
surgery showed an 18-25% and 9-13% improved survival for high-volume hospitals 
and high-volume surgeons respectively, compared to their low-volume counterparts. 
This difference in survival was not solely due to a decreased early postoperative 
mortality, since even after exclusion of early deaths, a 15% benefit was observed.  
Surgeon volume appears to be more strongly related to survival than hospital 
volume.   
